Multifunctionality is the only beauty trend that promises to make a product cheaper, and it is the one most likely to make the manufacturing quote go up. The consumer logic is sound and it is not going away: shoppers under pressure want fewer bottles, shorter routines and a defensible cost per use, and the industry has answered with tinted moisturisers carrying SPF, shampoo-conditioner hybrids, cleansing balms that claim to remove make-up and treat the barrier, body washes that claim to firm. What almost never survives the trend deck is the arithmetic underneath. A single product carrying four claims is not one product’s worth of evidence. It is four evidence packages in one jar, assessed under rules that were written on the assumption that a cosmetic does mainly one thing. This piece walks through the three rules that actually decide whether a hybrid saves money, using the primary texts rather than the marketing.

Written and researched by Evelyn Chong, Cosmetic Chemist & OEM Industry Analyst · Article type: Independent Editorial · Scope: claims substantiation, product-category and sourcing consequences of multifunctional personal care, with Malaysian, ASEAN and European Union reference points · Research period: September 2026 · Last reviewed: September 2026 · Corrections: via the site contact page.

Quick answer: is a multifunctional product cheaper to develop than two products?

Usually no, and the reason is regulatory rather than chemical. Each function a product claims must be substantiated on its own evidence, so a moisturiser that also claims sun protection and anti-dandruff activity needs three separate substantiation files, not one. Malaysia’s cosmetic claims guideline goes further: a cosmetic is defined by its main function, and a second function is permitted only as a “secondary, minor” one drawn from a short published list. Hybrids do save money on packaging, filling and shipping, and often on the customer’s acquisition cost. They rarely save money on testing. Decide which of those two budgets matters more before the brief is written.

Key takeaways

  • Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) tests cosmetic status against the product’s intended main function, and allows a secondary function only if it is minor. The acceptable secondary areas are published as a short list of eight.
  • The Malaysian sunscreen guideline explicitly does not apply to products making secondary UV claims — moisturisers and colour cosmetics among them. That gap removes the SPF classification table and the mandatory warning from hybrid SPF products, which is a commercial convenience domestically and a liability the moment the product is exported.
  • The European Commission’s technical document on cosmetic claims contains a rule aimed squarely at multifunctional ingredients: a “free from” claim is not allowed where the formula contains an ingredient with multiple functions and one of those functions is the one being disclaimed.
  • Savings from multifunctionality are real but sit almost entirely on the physical side — one pack, one fill, one carton, one shipment. The evidence side scales with the number of claims, not the number of bottles.
  • The cheapest hybrid to develop is the one where the added function needs no separate performance test, because it is a sensory or cosmetic benefit rather than a measured one.

Who this is for

This is written for brand founders, category managers and sourcing leads about to brief a 2-in-1, 3-in-1 or “hybrid” product to a contract manufacturer, and for the person who has to explain to a board why the multifunctional SKU that was supposed to consolidate the range came back with a longer timeline. It assumes you are selling in Malaysia or ASEAN, with an eye on European or United Kingdom export. It does not cover over-the-counter drug pathways, which is a different regime with different economics.

What does Malaysia’s “main function” rule mean for a multifunctional product?

A product qualifies as a cosmetic in Malaysia partly on the basis of what it is mainly for, not on the full list of things it does. The NPRA’s Guideline for Cosmetic Claims (Annex I, Part 8, August 2022) sets out a five-step decision process, and the third step is the one that matters here. The product must be applied to the permitted parts of the body “with a view exclusively or mainly to clean them, perfuming them, changing their appearance and/or correcting body odours and/or protecting them or keeping them in good condition.”

The words “exclusively or mainly” are doing a great deal of work. They mean the regulator is looking for a dominant purpose. A product that presents four co-equal functions has no dominant purpose to point at, and the assessment shifts from “is this claim acceptable” to the more dangerous “is this still a cosmetic.”

The guideline then makes room for a second function, but carefully: “products may have a secondary, minor function that is outside the above scope,” followed by a non-exhaustive list of eight acceptable secondary claim areas — dandruff, cellulite, bust contouring, anti-bacterial, caries, hair loss, acne and mouth wash. Two features of that list are worth pausing on. First, the qualifying adjective is minor, so a body wash whose entire marketing story is its anti-bacterial performance is not using an acceptable secondary claim; it is using an unacceptable primary one. Second, the list is short and specific, which means a novel hybrid function outside it has no pre-approved landing spot and will be assessed on its own.

The practical read for a buyer: multifunctionality is safest when the added functions are cosmetic in nature — hydration, softening, smoothing, appearance, scent — and gets progressively riskier as they drift toward things a consumer would describe as treating something. A cleansing balm that removes make-up and leaves skin comfortable is one product with several cosmetic effects. A cleansing balm that removes make-up and clears acne is a cosmetic with a regulated secondary claim, and the balance of the artwork has to show it.

Why does SPF behave differently in a hybrid than in a sunscreen?

This is the single most commercially significant asymmetry in multifunctional beauty, and it is easy to miss because it is stated in a scope note rather than a rule. Malaysia’s Guideline for Sunscreen Product (Annex I, Part 9(i), August 2022) opens by limiting itself: it “applies only to sunscreen products whose primary function is UV protection,” and “does not apply to products which make secondary UV protection claims, such as moisturising/skin lightening products and colour cosmetics/make up.”

Everything that follows in that guideline therefore attaches to the dedicated sunscreen and not to the hybrid. The SPF classification bands — low at 6 to under 15, medium at 15 to under 30, high at 30 to under 50, very high at 50 and above, with anything over 50 labelled as SPF 50+ — are written for the sunscreen. So is the mandatory warning statement, “Do not stay too long in the sun, even while using a sunscreen product.” So is the prohibition on implying whole-day protection, and the instruction that no UV protection claim should be made below SPF 6.

A brand reading this quickly concludes that a day cream with SPF is the cheaper route, and in the narrow Malaysian sense that is arguably true. It is also the wrong conclusion to build a range on, for three reasons.

The first is that the scope note limits the guideline, not the underlying obligation to substantiate. If the pack says SPF 30, the number still has to be a real number, and the guideline itself names the recognised in-vivo route for establishing it: ISO-published sun protection test methods, specifically ISO 24444, alongside AS/NZS 2604:2012 and the United States Food and Drug Administration’s 2011 Final Rule. An SPF panel test on a finished formula is the expensive item in a hybrid’s development budget, and being outside the sunscreen guideline does not make it optional.

The second is export. The moment the same tinted moisturiser is placed on the European Union market, it is assessed under Commission Regulation (EU) No 655/2013 and the common criteria, where the claim is judged on evidential support regardless of whether UV protection is the product’s headline function. A regulatory convenience that exists only in one market is not a saving; it is a deferred cost.

The third is the consumer-protection reality that sits behind the trend. A hybrid SPF product is typically applied in a far thinner layer than a sunscreen, because people apply moisturiser like moisturiser. The number on the pack was generated at the standard application density used in testing. Brands that treat the hybrid as a genuine sun-protection product rather than a lightly protective cosmetic invite a complaint they will struggle to answer. If sun protection is the point, sell a sunscreen; our earlier analysis of what brands are really buying when they buy sun care covers what changes when UV protection becomes the primary function.

The multifunctional-ingredient trap in “free from” claims

There is a second meaning of multifunctionality that buyers routinely conflate with the first. A multifunctional product does several things for the consumer. A multifunctional ingredient does several things inside the formula — typically a glycol or glyceryl ester that acts as a humectant or solubiliser while also suppressing microbial growth. These ingredients are the reason so many modern formulas carry short, clean-looking ingredient lists, and they are why the “preservative-free” claim proliferated.

The European Commission’s Technical document on cosmetic claims, whose Annex III on “free from” claims has applied since 1 July 2019, addresses this directly. Under the legal-compliance criterion it states that “free from” claims or claims addressing functional groups of ingredients “should not be allowed if the product contains ingredients with multiple functions and among these is the function that the product is claimed to be free from,” while allowing that exceptions might be possible, for example on the basis of challenge-test results for the formula without the particular ingredients.

Read that against a typical hybrid formula and the problem is obvious. The ingredient that lets a brand shorten the list is also the ingredient that forecloses the claim the short list was meant to support. The escape route named in the guidance is a real one, but it is a laboratory route: you demonstrate through preservation-efficacy testing — the challenge test standardised as ISO 11930, using five specified organisms over a 28-day observation — that the formula is adequately protected without relying on the ingredient in question. That is an additional test on an additional formula variant, which is to say another line in the development budget.

The same document is worth reading for a related trap that catches hybrids from the other direction. Under the honesty criterion it notes that “if the claimed performance of a shampoo is based on the combined use of that shampoo with a hair conditioner, this should be specified.” A 2-in-1 that quietly relies on a second step is the mirror image of a hybrid that claims to replace one. Both are honesty problems, and both are found in artwork review rather than in the lab. Our piece on what clean and sustainable claims actually have to prove sets out the wider substantiation regime these rules sit inside.

What each added function actually costs to substantiate

The table below is our own working model of how claim-stacking translates into evidence obligations. It is a planning aid rather than a quotation: real costs depend on the laboratory, the panel size, the market and how much of the work a manufacturer already holds for a base formula. What it is meant to show is the shape of the curve — that some added functions are nearly free and others reset the timeline.

Added functionTypical evidence expectedReference pointEffect on timeline
Moisturising, softening, smoothingInstrumental or consumer-perception study on the finished formulaCommon criteria, evidential supportLow — often bundled with routine testing
Sensory or cosmetic appearance benefitConsumer perception, clearly presented as suchCommon criteria, honestyLow
Sun protection (SPF)In-vivo SPF determination on the finished formulaISO 24444; AS/NZS 2604:2012; FDA 2011 Final RuleHigh — panel scheduling plus reformulation risk
UVA protectionUVA protection factor determinationISO 24443 (in vitro)Moderate to high
Anti-dandruff, anti-acne, anti-bacterialEfficacy evidence plus confirmation the function stays minorNPRA Annex I Part 8 secondary-claim listHigh — plus a category-status question
“Free from” / short ingredient listChallenge test on the variant lacking the disclaimed functionISO 11930; EU technical document Annex IIIModerate — a second formula to test
Longer wear, hold, or transfer resistanceMethod-defined performance testing on the finished formulaCommon criteria, evidential supportModerate

The pattern is consistent. Functions that are perceived cost little to prove. Functions that are measured cost a great deal, because the measurement has to be made on the finished formula — and in a hybrid, the finished formula changes every time any other function is adjusted. That is the hidden multiplier. Reformulating a straight sunscreen to fix a sensory complaint triggers one retest. Reformulating a tinted SPF moisturiser to fix a shade drift can trigger the SPF retest as well, because the pigment load sits in the same film that produces the protection. Anyone budgeting a hybrid should read our checklist of cosmetic product testing before the first batch with the number of claims, not the number of SKUs, in mind.

Where the value in multifunctionality actually comes from

None of the above says hybrids are a bad idea. It says the saving is in a different column from where most briefs look for it.

The genuine savings are physical and commercial. One product means one primary pack, one closure, one decoration run, one filling changeover, one carton, one shipment and one line of inventory instead of two. For a brand with limited working capital that consolidation is often the difference between launching and not launching, and it compounds: fewer SKUs means fewer minimum order quantities to fund, which is usually the binding constraint on a young range. On the consumer side, a hybrid can win a place in a routine that a fifth separate bottle never would, and the cost per use in a shopper’s hands really is lower.

The savings that do not exist are in the evidence file, and in one under-discussed operational area: complaint diagnosis. When a single-function product underperforms, the brand knows which function failed. When a four-function product draws complaints, the brand is looking at a formula where any of four things might be the cause, and the manufacturer will need a structured elimination process to find it. Build that expectation into the relationship before launch rather than after.

The most durable version of the trend, in our reading, is the modest one. Two or three functions that are chemically compatible, that share a pH window, and where at most one of them requires a measured performance test. That product is genuinely cheaper than its separated equivalents. The 5-in-1 with an SPF number, an active claim and a “free from” flash is a marketing artefact wearing the costume of a value proposition — and the manufacturer usually knows it before the brand does. Our counterpart piece from the manufacturing side, on why a five-in-one brief tends to come back as a shorter list, describes what happens to these briefs at the bench.

What to ask a manufacturer before committing to a hybrid

Six questions, in the order they are most useful.

  • Which of these functions is the main one? If the manufacturer cannot answer in one sentence, the artwork will not be able to either. Settle the dominant purpose before the formula.
  • Which claims require a test on the finished formula, and which can travel on ingredient-level or base-formula data? This single split usually explains the whole quote.
  • If we change one function later, which tests repeat? Ask for the dependency map, not just the test list. It is the difference between a six-week and a sixteen-week change.
  • Do any of these functions share an incompatible pH window or phase? A hybrid that needs two pH environments is two products in a trench coat.
  • Does anything in this formula have a preservative-adjacent secondary function? Ask before designing artwork around a “free from” flash, not after.
  • Which markets are in scope at launch? A claim that is comfortable in Malaysia and awkward in the European Union should be discovered at the brief stage, since the decision is usually to change the claim rather than the market.

Frequently asked questions

Is a 2-in-1 shampoo legally simpler than a shampoo plus a conditioner?

It is simpler as a notification and as a supply chain, and no simpler as a claims matter. The cleaning function and the conditioning function are both cosmetic, so the product sits comfortably within the definition, but any performance claim attached to either still needs its own support. The specific trap is the reverse case: European guidance says that where a shampoo’s claimed performance depends on being used with a conditioner, that dependency must be stated. Test the hybrid on its own before claiming it replaces a step.

Can a moisturiser in Malaysia carry an SPF number without following the sunscreen guideline?

The sunscreen guideline states that it applies only to products whose primary function is UV protection and does not apply to products making secondary UV claims, which it lists as including moisturising products and colour cosmetics. That is a scope limitation on the guideline, not permission to publish an unsubstantiated number. The SPF value still has to be a determined value, and the recognised route named in the same guideline is in-vivo testing under ISO 24444 or an equivalent recognised standard. Treat the exemption as a labelling difference, not an evidence discount.

Why can’t we say “preservative-free” when there is no preservative on the ingredient list?

Because the assessment looks at function, not at which annex an ingredient sits in. European guidance says a “free from” claim should not be allowed where the product contains ingredients with multiple functions and one of those is the function being disclaimed — and separately, that “free from preservatives” should not be used where the product contains ingredients showing a protective effect against microorganisms even if they are not listed as preservatives. The exception route runs through challenge-test evidence, which means testing a version of the formula without the ingredient in question.

How many functions is too many?

There is no numeric limit in any of the source documents, which is precisely why the question is a commercial one rather than a regulatory one. The useful test is not how many functions there are but how many of them require a measured performance test on the finished formula. One is manageable. Two lengthens the timeline and couples the retests together. Three means every future formula change is a project. Count the measured claims, not the bullet points on the pack.

Does multifunctionality reduce the minimum order quantity?

Indirectly and usually yes, which is the strongest argument in its favour. Consolidating three SKUs into one means funding one minimum order quantity rather than three, and one set of components. That is a working-capital saving that arrives immediately, whereas the extra substantiation cost is largely one-off. For a brand whose constraint is cash rather than time, that trade can be worth making deliberately — provided the claims chosen are the cheap ones to prove.

Sources and further reading

Limitations

This article reads published regulatory guidance and international standards; it is not legal advice and it is not a substitute for a safety assessor’s view on a specific formula. The cost-and-timeline table is our own planning model built from the evidence obligations described in those documents, not a survey of laboratory pricing, and real figures vary widely by laboratory, panel size and market. Guideline documents are revised: the Malaysian guidelines cited here carry August 2022 dates and the European technical document is guidance rather than binding law. Verify the current version of any document before relying on it for a notification or a launch.

Update history

September 2026 — first publication.

This article is independent editorial research written for brand owners and sourcing teams. Product examples are illustrative and no specific manufacturer, laboratory or ingredient supplier is endorsed. Claims requirements differ by market and change over time; confirm current requirements with the relevant authority before committing to artwork or a launch date.